title: The Optimal Local Treatment of Stage IIIA-N2 NSCLC: Is the Issue Finally Settled?
authors.affiliation: Maastro Clinic, Maastricht, The Netherlands; Department of Radiation Oncology, Katholieke Universiteit Leuven, Leuven, Belgium. Electronic address: dirk.deruysscher@maastro.nl.
authors.forename: Dirk
authors.initials: D
authors.lastname: De Ruysscher
authors.affiliation: Department of Pulmonology, University Hospitals Leuven/Katholieke Universiteit Leuven, Belgium.
authors.forename: Johan
authors.initials: J
authors.lastname: Vansteenkiste
authors.affiliation: Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
authors.forename: José
authors.initials: J
authors.lastname: Belderbos
authors.affiliation: Department of Thoracic Surgery, University Hospitals Leuven/Katholieke Universiteit Leuven, Leuven, Belgium.
authors.forename: Herbert
authors.initials: H
authors.lastname: Decaluwé
authors.affiliation: Department of Pulmonology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Dingemans
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D016032:Randomized Controlled Trials as Topic